Skip to main content
- News
Asceneuron’s unique approach to treat Alzheimer’s disease featured by our CEO Dirk Beher in series of interviews with industry leaders on the future of Alzheimer's disease drug development.

In the article "Precision And Prevention Key To Future Of Alzheimer's Treatment - A Look at Novel Approaches In The Alzheimer's Pipeline" published by In Vivo on August 4th, 2021, William Masters gathered the recommentations of leading CEOs from early- to mid-stage biotechs to advance AD treatment.

Click here to read the article